RETIFANLIMAB

UNII:	2Y3T5IF01Z
Formula:
Preferred Substance Name:	RETIFANLIMAB

2079108-44-2
AEX1188
AEX-1188
ANTI-PD-1 MONOCLONAL ANTIBODY MGA012
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMANIZED MONOCLONAL MGA012 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL MGA012 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (PROTEIN PD-1CD279 ANTIGEN))MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV1-46*01 (82%) (IGHD)-IGHJ4*01 (93%)) (8.8.12) (1-119)-HOMO SAPIENS IGHG4*01 (HINGE (S10>P(227)),CH3(K107>DEL(446))) (120-445)) (133-218')-DISULFIDE WITH .KAPPA. LIGHT CHAIN CHIMERIC (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-2*01 (81%) IGKJ2*01 (92%))/(HOMO SAPIENS IGKV3D-11*02 (78%) IGKJ4*01 (100%))(10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (112'-218')), DIMER (225-225'':228-228'')-BISDISULFIDE
INCMGA00012
INCMGA-00012
MGA012
MGA-012
RETIFANLIMAB [INN]
RETIFANLIMAB [USAN]
RETIFANLIMAB [WHO-DD]
RETIFANLIMAB-DLWR
ZYNYZ

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RETIFANLIMAB

Synonyms and Mappings

Resources